Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:4
|
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] TOTAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) RESIDUAL RISK ASSOCIATED WITH INCREASED LIPOPROTEIN(A) LEVELS AMONG STATIN TREATED ADULTS WITH CARDIOVASCULAR DISEASE
    Wong, Nathan D.
    Zhao, Yanglu
    Sung, Jennifer
    Browne, Auris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1847 - 1847
  • [42] Association of mortality by statin intensity in chronic liver disease patients with atherosclerotic cardiovascular disease: A nationwide cohort study
    Bea, Sungho
    Oh, In-Sun
    Kim, Ju Hwan
    Sinn, Dong Hyun
    Chang, Yoosoo
    Ryu, Seungho
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 142 - 142
  • [43] Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors
    Hsu, Chia-Yun
    Chen, Wen-Jone
    Chen, Ho-Ming
    Tsai, Hsin-Yi
    Hsiao, Fei-Yuan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 415 - 423
  • [44] Cardiovascular Disease and Statin Drugs
    Campbell, Andrew W.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2014, 20 (05) : 8 - 9
  • [45] Remnant Cholesterol as a Residual Risk in Patients With Atherosclerotic Cardiovascular Disease Under ModerateIntensity Statin With Ezetimibe Combination Therapy or HighIntensity Statin Monotherapy
    Lee, Jung-Hee
    Ahn, Sung Gyun
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Ko, Young-Guk
    Kim, Jung-Sun
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Byeong-Keuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B97 - B98
  • [46] Periodontal disease and atherosclerotic cardiovascular disease
    Berent, Robert
    Sinzinger, Helmut
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2013, 42 (01) : 3 - 7
  • [47] Arterial imaging might optimize statin eligibility by current atherosclerotic cardiovascular disease risk calculation tools
    Kyriakoulis, Konstantinos G.
    Komnianou, Aikaterini
    Dimitriadis, Kyriakos
    Kollias, Anastasios
    ATHEROSCLEROSIS, 2025, 401
  • [48] Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes
    Markossian, Talar W.
    Kramer, Holly J.
    Burge, Nicholas J.
    Pacold, Ivan V.
    Leehey, David J.
    Huo, Zhiping
    Schneider, Julia
    Ling, Benjamin
    Stroupe, Kevin T.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (04) : 530 - 537
  • [49] Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?
    VanWagner, Lisa B.
    LIVER TRANSPLANTATION, 2018, 24 (07) : 865 - 867
  • [50] Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women
    Yunsheng Ma
    Gioia M. Persuitte
    Christopher Andrews
    Kathleen M. Hovey
    Michael J. LaMonte
    Annie L. Culver
    JoAnn E. Manson
    Lawrence S. Phillips
    Simin Liu
    Charles Eaton
    Lisa W. Martin
    Barbara V. Howard
    Raji Balasubramanian
    Chloe E. Bird
    Ira S. Ockene
    Susan R. Sturgeon
    Judith K. Ockene
    Lesley Tinker
    Rami Nassir
    Jacques Rossouw
    European Journal of Epidemiology, 2016, 31 : 747 - 761